Dothan Pharmaceutical Product Lawyer, Alabama

... noted above in Novartis II, the State's second amended complaint sets forth the same basic allegations against the 73 pharmaceutical companies ... of its drugs "was priced and marketed in light of competitive pressures and other variables in each individual product market." (Par's ...

... 10%—reduced the AWP. This formula is the product in large part of studies the AMA had conducted in 1985 and 1987 by two large pharmaceutical wholesalers of the average prices paid by pharmacies for prescription drugs. ...

... The pharmaceutical manufacturers argue that this case "share[s] none of the characteristics with those in which this Court has[, in the past ... GSK's petition at 6. They argue that this Court has endorsed consolidation "in cases involving a single, identifiable product or event," such ...